Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Brett Riedinger

Vascular & Interventional Radiology Indianapolis, IN Medical Doctor

NPI 1376078618 CMS profile 7412105

550 University Blvd, Indianapolis, IN 46202

Open in the dashboard

General payments

$6,581

73 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brett Riedinger of Indianapolis, IN is reported in the CMS Open Payments database as having received $6,581 across 73 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,073 59
2024 General $1,242 11
2023 General $233 2
2022 General $34 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brett Riedinger
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Brett Riedinger were reported at $5,073. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Brett Riedinger Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $0 $280 $99–$866 $132
2022 $34 $433 $137–$1,497 $149
2023 $233 $506 $152–$2,019 $160
2024 $1,242 $556 $175–$1,930 $164
2025 $5,073 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. AngioDynamics, Inc. $3,473 21 payments
  2. Medtronic, Inc. $1,952 17 payments
  3. Stryker Corporation $545 28 payments
  4. Inari Medical, Inc. $361 2 payments
  5. Boston Scientific Corporation $125 1 payment
  6. Imperative Care, INc $53 2 payments
  7. Penumbra, Inc. $40 1 payment
  8. Terumo Medical Corporation $34 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $3,652 16 payments
  2. Food and Beverage $2,929 57 payments
Products named General payments · program years 2022–2025
  1. ALPHAVAC $2,364 19 payments
  2. KYPHON EXPRESS II KYPHOPAK TRAY $1,952 17 payments
  3. ANGIOVAC $1,109 2 payments
  4. FLOWTRIEVER CATHETER, S $379 3 payments
  5. CT THROMBECTOMY SYSTEM KIT $379 3 payments
  6. OBSIDIO $125 1 payment
  7. CLOTTRIEVER BOLD CATHETER $114 6 payments
  8. VENACORE THROMBECTOMY CATHETER $111 5 payments
  9. FLOWTRIEVER $70 4 payments
  10. INTHRILL THROMBECTOMY CATHETER $69 2 payments
  11. Other $288 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

73 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record